Fear extinction requires Arc/Arg3.1 expression in the basolateral amygdala
- Kousuke Onoue†1,
- Daisuke Nakayama†1,
- Yuji Ikegaya1, 2,
- Norio Matsuki1 and
- Hiroshi Nomura1Email author
© Onoue et al.; licensee BioMed Central Ltd. 2014
Received: 24 December 2013
Accepted: 16 April 2014
Published: 23 April 2014
Prolonged re-exposure to a fear-eliciting cue in the absence of an aversive event extinguishes the fear response to the cue, and has been clinically used as an exposure therapy. Arc (also known as Arg3.1) is implicated in synaptic and experience-dependent plasticity. Arc is regulated by the transcription factor cAMP response element binding protein, which is upregulated with and necessary for fear extinction. Because Arc expression is also activated with fear extinction, we hypothesized that Arc expression is required for fear extinction.
Extinction training increased the proportion of Arc-labeled cells in the basolateral amygdala (BLA). Arc was transcribed during latter part of extinction training, which is possibly associated with fear extinction, as well as former part of extinction training. Intra-BLA infusions of Arc antisense oligodeoxynucleotide (ODN) before extinction training impaired long-term but not short-term extinction memory. Intra-BLA infusions of Arc antisense ODN 3 h after extinction training had no effect on fear extinction.
Our findings demonstrate that Arc is required for long-term extinction of conditioned fear and contribute to the understanding of extinction as a therapeutic manner.
KeywordsArc/Arg3.1 Fear conditioning Extinction Amygdala
Excessive fear is related to the pathogenesis of psychiatric disorders such as post-traumatic stress disorder. Prolonged re-exposure to a fear-eliciting cue in the absence of aversive events reduces the fear response to the cue, and has been clinically used as an exposure therapy. De novo gene expression contributes to the consolidation of fear extinction. In fact, activation of the transcription factor cAMP response element binding protein (CREB) increases with fear extinction, and its blockade impairs fear extinction . Inhibition of protein synthesis also impairs fear extinction .
Reduction of synaptic strength is proposed as a cellular mechanism for fear extinction , which is accompanied by reduced firing of amygdala neurons  and a decrease in the surface expression of α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors (AMPARs) . These mechanisms are supported by experiments demonstrating that the disruption of AMPAR endocytosis impairs fear extinction [5, 6].
The activity-regulated cytoskeletal-associated protein (Arc, also known as Arg3.1) is transcribed during robust neural activity [7, 8] and is involved in the inhibition of synaptic strength . Increased expression of Arc reduces AMPAR-mediated synaptic transmission by accelerating receptor endocytosis [10, 11]. Arc transcription is regulated by CREB , which is upregulated with and necessary for fear extinction . Because Arc expression is also activated with fear extinction , we hypothesized that Arc expression would be required for fear extinction. We chose the basolateral amygdala (BLA) as a target region because gene expression here is essential for fear extinction . In this study, we tested whether Arc expression in the BLA is required for extinction of contextual conditioned fear.
Arc expression is upregulated in the BLA after extinction training
Inhibiting Arc translation in the BLA impairs long-term extinction of conditioned fear
Time-limited effect of inhibiting Arc translation in the BLA on fear extinction
In this study, we have demonstrated the involvement of Arc in fear extinction. We found that 1) extinction training increased the proportion of Arc-labeled cells in the BLA; 2) Arc was transcribed during latter part as well as former part of extinction training; 3) intra-BLA infusions of Arc antisense ODN before extinction training impaired long-term but not short-term extinction memory; and 4) intra-BLA infusions of Arc antisense ODN 3 h after extinction training had no effect on fear extinction. Collectively, these findings indicate that de novo Arc expression, induced by extinction training, contributes to long-term extinction of contextual conditioned fear.
Our study design suggests that this impaired extinction of conditioned fear cannot be explained by a nonspecific effect of intra-BLA infusions of Arc antisense ODN. First, the Arc antisense ODN effectively inhibited Arc expression and exhibited a high degree of specificity for Arc relative to other immediate-early genes (IEGs) (Additional file 1). Second, the behavior of the mice that received Arc antisense ODN during extinction training and the short-term memory test was comparable to that of the mice that received scrambled ODN, indicating that the antisense ODN had no effect on retrieval of fear memory and acquisition of extinction memory. More importantly, fear extinction in the mice that received Arc antisense ODN 3 h after extinction training was intact, indicating that extinction training-induced Arc translation is essential for fear extinction.
Arc may contribute to fear extinction by reducing synaptic strength. Fear memory is thought to be maintained by fear conditioning-induced potentiation of synaptic efficacy in amygdalar synapses [15, 16]. Extinction training reverses this potentiation through accelerated endocytosis of AMPAR . This endocytosis-regulated depotentiation is likely an essential mechanism for fear extinction, because inhibiting AMPAR endocytosis impairs fear extinction [5, 6]. In this study, we found that Arc expression is required for fear extinction. Arc interacts with endophilin and dynamin to modulate AMPAR endocytosis , thus allowing Arc to influence synaptic strength and homeostasis [9, 17]. Taken as a whole, extinction training induces Arc expression, which possibly accelerates AMPAR endocytosis and reverses fear conditioning-induced synaptic potentiation. The resulting depotentiation is likely to contribute to fear extinction.
In short, our findings provide evidence that Arc is critical for long-term extinction of conditioned fear, and that activation of Arc signaling in the BLA might lead to long-term extinction of fear memory through reversal of fear conditioning-induced synaptic potentiation. A better understanding of the mechanisms underlying fear extinction is necessary for the development of new treatments for psychiatric disorders such as post-traumatic stress disorder. These data suggest that a BLA Arc-regulated pathway could generate viable targets for these potential new therapies.
Materials and methods
Animal experiment ethics
All experiments were approved by the animal experiment ethics committee at the University of Tokyo (approval number 24–10), and were in accordance with the University of Tokyo guidelines for the care and use of laboratory animals.
Male C57BL/6J mice (Japan SLC Inc., Shizuoka, Japan), weighing 20–30 g and aged 8–13 weeks, were housed 2–4 per cage, and kept on a 12-h light/dark cycle (lights on from 7:00 a.m. to 7:00 p.m.). They were given free access to food and water, and acclimated to daily handling for 1 week prior to the start of the study.
Contextual fear conditioning, extinction training, and subsequent testing were performed in a conditioning chamber (17 cm wide, 15 cm deep, and 15 cm high) with a stainless steel grid floor (O’ Hara & Co., Ltd, Tokyo, Japan). A conditioning session consisted of placing the animal in the chamber and delivering a 2-s foot shock (0.3 mA) after 130 s. The mice then received 2 additional shocks every 100 s. They were kept in the chamber for an additional 50 s and were then returned to their home cage. For extinction training and testing, mice were re-exposed to the conditioning chamber without shock. All sessions were performed between 9:00 a.m. and 1:00 p.m., and each session was video-recorded for automatic scoring of freezing as described previously .
In Experiment 1, mice in the Extinction group underwent 40 min of extinction training 24 h after fear conditioning and were killed 90 min later. Mice in the No Extinction group received fear conditioning, and 1 day later, they were killed immediately following removal from the home cage. Their brain slices were subjected to Arc immunohistochemistry.
In Experiment 2, mice in the Extinction group underwent 35 min of extinction training 24 h after fear conditioning and were killed immediately after extinction training. Their brain slices were subjected to Arc fluorescent in situ hybridization.
In Experiment 3, we examined the effect and specificity of Arc antisense ODN. Mice received Arc antisense or scrambled ODN infusions into the hippocampus and underwent fear conditioning 1.5 or 3 h later. Mice were decapitated after diethyl ether anesthesia 2 h after fear conditioning, and their brains were rapidly removed and frozen at −80°C. Coronal brain sections (300 μm) were prepared using a cryostat. The dorsal hippocampus (1.30 to 1.90 mm posterior to bregma) was punched out and homogenized in RIPA buffer (08714–04, Nacalai Tesque, Kyoto, Japan).
In Experiment 4, mice underwent extinction training 24 h after fear conditioning. To determine if Arc inhibition affected fear extinction, mice received intra-BLA infusions of either Arc antisense or scrambled ODN 3 h before extinction training, and were subjected to a short-term and long-term memory tests 2 h and 24 h later, respectively.
In Experiment 5, mice underwent extinction training 24 h after fear conditioning. To assess the effect of the post-extinction training time interval, mice received intra-BLA infusions of either Arc antisense or scrambled ODN 3 h after extinction training and were subjected to a long-term memory test 24 h later.
Surgery for intra-BLA infusions was conducted according to our previous study . Briefly, mice were anesthetized with pentobarbital (2.5 mg/kg, i.p.) and xylazine (10 mg/kg, i.p.), and 26-gauge stainless-steel guide cannulae (Plastics One, VA, USA) were implanted in the BLA (AP = −1.4, ML = ±3.5, DV = −4.8 mm relative to bregma). Mice were given at least 7 days of postoperative recovery time. Microinfusions of Arc antisense or scrambled ODN (400 pmol; 0.5 μL/side) were made over 2 min, and the infusion cannulae were left in place for at least 2 min afterwards in order to facilitate the diffusion of ODN throughout the whole BLA.
Arc antisense ODN and scrambled ODN (GeneDesign Inc, Osaka, Japan) were designed in reference to a previous study . The Arc ODN encoded an antisense sequence for the Arc mRNA sequence near the translation start site . The scrambled ODN does not show significant homology to any sequences in the GenBank database . Both ODNs contained phosphorothioate linkages on the three terminal bases of both the 5′ and 3′ ends, and phosphodiester internal bonds. This design is reported more stable than unmodified phosphorothioated ODNs in vivo, and less toxic than fully phosphorothioated ODNs . The following sequences were used (“~” denotes a phosphorothioate linkage): 5′-G~T~C~CAGCTCCATCTGGT~C~G~T-3′ (antisense) and 5′-C~G~T~GCACCTCTCGCAGG~T~T~T-3′ (scrambled).
In the Experiment 3, the guide cannulae were implanted in the dorsal hippocampus (−2.0, ±1.7, −2.1 mm relative to bregma).
Immunohistochemistry and image analysis
After the anesthetization, mice were transcardially perfused with PBS followed by 4% paraformaldehyde (PFA). Brains were post-fixed in 4% PFA for 12 h. Free-floating coronal sections (40 μm) were prepared using a cryostat (HM520; Thermo Fisher Scientific, Waltham, MA, USA). Arc was visualized with anti-Arc primary antibody (1:1,000; SySy, Gottingen, Germany), biotinylated anti-rabbit secondary antibody (1:500; Vector Laboratories, Burlingame, CA, USA), VECTASTAIN ABC Kit (Vector Laboratories), and Cy3-tyramide (1:100; Perkin-Elmer, Waltham, MA, USA). Nuclei were counterstained with Hoechst dye (1:1000; Invitrogen).
Images of the amygdala were acquired by z-stacks using a confocal microscope (CV1000; YOKOGAWA, Tokyo, Japan) at 40 × under an oil-immersion lens (NA 1.3). Images of BA and LA from three sections (1.34, 1.58, 1.82 mm posterior to bregma) per mouse were analyzed using ImageJ (NIH).
Fluorescent in situ hybridization and image analysis
After the mice were sacrificed, the brains were frozen quickly and stored at −80°C until further processing. Brains were sectioned (20 μm) with a cryostat, mounted on slides and stored at −80°C. Antisense riboprobes for Arc, conjugated to digoxigenin-UTP (Roche Applied Science, Penzberg, Germany), were generated from cDNA plasmid (provided by Dr. Paul F Worley) containing an almost full-length cDNA of the Arc transcript using MAXIScript (Ambion, Austin, TX USA). In situ hybridization was performed according to previously published protocols . Slide-mounted brain sections were fixed in 4% PFA, acetylated with 0.5% acetic anhydride/1.5% triethanolamine, dehydrated through 50% methanol/50% acetone solutions, and equilibrated in 2× saline sodium citrate buffer (SSC). Slides were incubated in prehybridization buffer for 30 min. The antisense riboprobe was diluted to 150 μL in hybridization buffer, heat denatured, chilled on ice, and applied to each slide. Hybridization was carried out at 56°C for 16 h. Slides were washed to a final stringency of 0.5×SSC at 56°C, which included an earlier wash step at 37°C in 2×SSC with RNase A (10 μg/mL). Endogenous peroxidase activity was quenched with 2% H2O2 in 1×SSC. Slides were blocked with TSA blocking reagent (PerkinElmer, Waltham, MA, USA) and incubated with an anti-digoxigenin horseradish peroxidase conjugate (1:500, Roche) for 2 h. Slides were washed three times in Tris-buffered saline with 0.05% Tween-20, and incubated with fluorescein-tyramine working solution (1:10, PerkinElmer). Slides were washed in PBS and the nuclei were counterstained with propidium iodide (PI, 10 μM; Life Technologies) for 10 min. Finally, the sections were washed with PBS and mounted in Permafluor (Thermo Fisher Scientific, Waltham, MA, USA).
Images of the BLA (1.58 mm posterior to bregma) were acquired by collecting z-stacks using a confocal microscope (LSM-510; Zeiss, Oberkochen, Germanay) at 40× under an water-immersion lens (NA 1.2) and analyzed using in-house Matlab program. From 4 to 8 sections per mouse were counted for the analysis. Only cells that contained whole nuclei and were presumptive neurons, with large nuclei stained diffusely with propidium iodide, were included in the analysis. The designation “nuclear Arc positive” was assigned to neurons that exhibited 1 or 2 of the characteristic intense intranuclear areas of fluorescence; the designation “cytoplasmic Arc positive” was assigned to neurons that contained perinuclear/cytoplasmic labeling over multiple optical sections. Labels were assigned by an experimenter blind to behavioral conditions.
Protein concentrations were normalized across homogenates using a Bradford assay. Equal amounts of protein were electrophoresed on 5-20% SDS polyacrylamide gels and transferred to PVDF membranes. Western blots were blocked in blocking buffer (03953–95, Nacalai Tesque) and then incubated with an anti-beta-actin antibody (1:1000; A5441, Sigma), an anti-Arc/Arg3.1 antibody (1:1000; sc-17839, Santa Cruz Biotechnology), anti-c-Fos antibody (1:100; Ab-2, Calbiochem) or anti-Zif268 antibody (1:1000; #4153, Cell Signaling). After incubation with anti-mouse IgG (1:100000; A9044, Sigma) or anti-rabbit IgG (1:10000; 01827–44, Nacalai Tesque), bands were developed with a chemiluminescent substrate (RPN2132, GE Healthcare). The immunopositive signals were detected by ImageQuant LAS 4000 (GE Healthcare) and analyzed using ImageJ (NIH).
All values were reported as mean ± SEM. Statistical analysis was performed using Student’s t-test, repeated-measures ANOVA, one-way ANOVA and Tukey’s test.
Activity-regulated cytoskeletal-associated protein
cAMP response element binding protein
α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor
cellular analysis of temporal activity by fluorescence in situ hybridization.
We thank Dr. Paul F Worley for the Arc cDNA. This work was supported by Grant-in-Aid for Young Scientists (B) (25830002, to HN), Grant-in-Aid for Scientific Research on Innovative Areas, “Mesoscopic Neurocircuitry” (No. 23115101, to HN), “The Science of Mental Time” (No. 26119507 to HN and No. 25119004 to YI) and “Memory Dynamism” (No. 26115509 to HN).
- Mamiya N, Fukushima H, Suzuki A, Matsuyama Z, Homma S, Frankland PW, Kida S: Brain region-specific gene expression activation required for reconsolidation and extinction of contextual fear memory. J Neurosci. 2009, 29 (2): 402-413. 10.1523/JNEUROSCI.4639-08.2009.PubMedView ArticleGoogle Scholar
- Vianna MR, Szapiro G, McGaugh JL, Medina JH, Izquierdo I: Retrieval of memory for fear-motivated training initiates extinction requiring protein synthesis in the rat hippocampus. Proc Natl Acad Sci U S A. 2001, 98 (21): 12251-12254. 10.1073/pnas.211433298.PubMedPubMed CentralView ArticleGoogle Scholar
- Orsini CA, Maren S: Neural and cellular mechanisms of fear and extinction memory formation. Neurosci Biobehav Rev. 2012, 36 (7): 1773-1802. 10.1016/j.neubiorev.2011.12.014.PubMedPubMed CentralView ArticleGoogle Scholar
- Quirk GJ, Repa C, LeDoux JE: Fear conditioning enhances short-latency auditory responses of lateral amygdala neurons: parallel recordings in the freely behaving rat. Neuron. 1995, 15 (5): 1029-1039. 10.1016/0896-6273(95)90092-6.PubMedView ArticleGoogle Scholar
- Kim J, Lee S, Park K, Hong I, Song B, Son G, Park H, Kim WR, Park E, Choe HK, Kim H, Lee C, Sun W, Kim K, Shin KS, Choi S: Amygdala depotentiation and fear extinction. Proc Natl Acad Sci U S A. 2007, 104 (52): 20955-20960. 10.1073/pnas.0710548105.PubMedPubMed CentralView ArticleGoogle Scholar
- Dalton GL, Wang YT, Floresco SB, Phillips AG: Disruption of AMPA receptor endocytosis impairs the extinction, but not acquisition of learned fear. Neuropsychopharmacology. 2008, 33 (10): 2416-2426. 10.1038/sj.npp.1301642.PubMedView ArticleGoogle Scholar
- Lyford GL, Yamagata K, Kaufmann WE, Barnes CA, Sanders LK, Copeland NG, Gilbert DJ, Jenkins NA, Lanahan AA, Worley PF: Arc, a growth factor and activity-regulated gene, encodes a novel cytoskeleton-associated protein that is enriched in neuronal dendrites. Neuron. 1995, 14 (2): 433-445. 10.1016/0896-6273(95)90299-6.PubMedView ArticleGoogle Scholar
- Link W, Konietzko U, Kauselmann G, Krug M, Schwanke B, Frey U, Kuhl D: Somatodendritic expression of an immediate early gene is regulated by synaptic activity. Proc Natl Acad Sci U.S.A. 1995, 92 (12): 5734-5738. 10.1073/pnas.92.12.5734.PubMedPubMed CentralView ArticleGoogle Scholar
- Shepherd JD, Bear MF: New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci. 2011, 14 (3): 279-284. 10.1038/nn.2708.PubMedView ArticleGoogle Scholar
- Rial Verde EM, Lee-Osbourne J, Worley PF, Malinow R, Cline HT: Increased expression of the immediate-early gene arc/arg3.1 reduces AMPA receptor-mediated synaptic transmission. Neuron. 2006, 52 (3): 461-474. 10.1016/j.neuron.2006.09.031.PubMedPubMed CentralView ArticleGoogle Scholar
- Chowdhury S, Shepherd JD, Okuno H, Lyford G, Petralia RS, Plath N, Kuhl D, Huganir RL, Worley PF: Arc/Arg3.1 interacts with the endocytic machinery to regulate AMPA receptor trafficking. Neuron. 2006, 52 (3): 445-459. 10.1016/j.neuron.2006.08.033.PubMedPubMed CentralView ArticleGoogle Scholar
- Kawashima T, Okuno H, Nonaka M, Adachi-Morishima A, Kyo N, Okamura M, Takemoto-Kimura S, Worley PF, Bito H: Synaptic activity-responsive element in the Arc/Arg3.1 promoter essential for synapse-to-nucleus signaling in activated neurons. Proc Natl Acad Sci U.S.A. 2009, 106 (1): 316-321. 10.1073/pnas.0806518106.PubMedPubMed CentralView ArticleGoogle Scholar
- Maddox SA, Schafe GE: The activity-regulated cytoskeletal-associated protein (Arc/Arg3.1) is required for reconsolidation of a Pavlovian fear memory. J Neurosci. 2011, 31 (19): 7073-7082. 10.1523/JNEUROSCI.1120-11.2011.PubMedPubMed CentralView ArticleGoogle Scholar
- Guzowski JF, Lyford GL, Stevenson GD, Houston FP, McGaugh JL, Worley PF, Barnes CA: Inhibition of activity-dependent arc protein expression in the rat hippocampus impairs the maintenance of long-term potentiation and the consolidation of long-term memory. J Neurosci. 2000, 20 (11): 3993-4001.PubMedGoogle Scholar
- McKernan MG, Shinnick-Gallagher P: Fear conditioning induces a lasting potentiation of synaptic currents in vitro. Nature. 1997, 390 (6660): 607-611. 10.1038/37605.PubMedView ArticleGoogle Scholar
- Rogan MT, Staubli UV, LeDoux JE: Fear conditioning induces associative long-term potentiation in the amygdala. Nature. 1997, 390 (6660): 604-607. 10.1038/37601.PubMedView ArticleGoogle Scholar
- Shepherd JD, Rumbaugh G, Wu J, Chowdhury S, Plath N, Kuhl D, Huganir RL, Worley PF: Arc/Arg3.1 mediates homeostatic synaptic scaling of AMPA receptors. Neuron. 2006, 52 (3): 475-484. 10.1016/j.neuron.2006.08.034.PubMedPubMed CentralView ArticleGoogle Scholar
- Nomura H, Matsuki N: Ethanol enhances reactivated fear memories. Neuropsychopharmacology. 2008, 33 (12): 2912-2921. 10.1038/npp.2008.13.PubMedView ArticleGoogle Scholar
- Nakayama D, Yamasaki Y, Matsuki N, Nomura H: Post-retrieval late process contributes to persistence of reactivated fear memory. Learn Mem. 2013, 20 (6): 307-310. 10.1101/lm.029660.112.PubMedView ArticleGoogle Scholar
- Nomura H, Nonaka A, Imamura N, Hashikawa K, Matsuki N: Memory coding in plastic neuronal subpopulations within the amygdala. Neuroimage. 2012, 60 (1): 153-161. 10.1016/j.neuroimage.2011.12.022.PubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.